421 related articles for article (PubMed ID: 34153312)
1. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
Pan K; Chen S; Wang Y; Yao W; Gao X
Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
[TBL] [Abstract][Full Text] [Related]
3. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
5. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
6. miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways.
Jiang H; Liu J; Guo S; Zeng L; Cai Z; Zhang J; Wang L; Li Z; Liu R
Mol Ther Nucleic Acids; 2022 Jun; 28():539-557. PubMed ID: 35592504
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
8. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
10. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
[TBL] [Abstract][Full Text] [Related]
11. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
12. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
14. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
15. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
16. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
17. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide Protects Against Brain Amyloid-β
Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease.
Patrick E; Rajagopal S; Wong HA; McCabe C; Xu J; Tang A; Imboywa SH; Schneider JA; Pochet N; Krichevsky AM; Chibnik LB; Bennett DA; De Jager PL
Mol Neurodegener; 2017 Jul; 12(1):51. PubMed ID: 28668092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]